Search Results 1311-1320 of 11232 for Antifungal Resistance

  1. Cutaneous T-cell lymphoma

    DeVita VT Jr, et al., eds. Cutaneous lymphomas. In: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed.

  2. A Study To Compare The Effectiveness And Safety Of JCAR017 To Standard Of Care In Adult Subjects With High-risk, Transplant-eligible Relapsed Or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    Subjects with uncontrolled systemic fungal, bacterial, viral or other infection (including tuberculosis) despite appropriate antibiotics or other treatment.

  3. Cutaneous T-cell lymphoma

    DeVita VT Jr, et al., eds. Cutaneous lymphomas. In: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed.

  4. A Study Of Andecaliximab In Participants With Fibrodysplasia Ossificans Progressiva (FOP) - Mayo Clinic

    Known active infection (including fungal, bacterial, mycobacterial, or viral infection including COVID19). Uncontrolled hypoparathyroidism or ...

  5. Nivolumab And Brentuximab Vedotin After Stem Cell Transplant In Treating Patients With Relapsed Or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab and brentuximab vedotin, may interfere with the ability of cancer cells to grow and spread. Participation eligibility.

  6. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) In Subjects With Recurrence Of Clostridium Difficile Infection - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of CP101 treatment in adults who had a Clostridum difficile Infection (CDI) recurrence ...

  7. Drugs and Supplements that Start with R - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “R” to learn about drug side effects, proper use and ...

  8. Alemtuzumab (intravenous route) - Side effects & uses - Mayo Clinic

    Alemtuzumab may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. In addition, other ...

  9. Oncology (Medical) - Clinical trials

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...

  10. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Q&A podcast: Tackling the latest COVID-19 topics featured image · Proton therapy induces biologic response to attack treatment-resistant cancers ...